Low serum testosterone is associated with increased mortality in men with stage 3 or greater nephropathy

American Journal of Nephrology

Volumn 33, Issue 3, 2011, Pages 209-217

  Haring, Robin ^a   Nauck, Matthias ^a   Völzke, Henry ^a   Endlich, Karlhans ^a   Lendeckel, Uwe ^a   Friedrich, Nele ^a   Dörr, Marcus ^a   Rettig, Rainer ^a   Kroemer, Heyo K ^a   Wallaschofski, Henri ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Albuminuria; Estimated glomerular filtration rate; Kidney disease; The Study of Health in Pomerania; Total testosterone

Indexed keywords

ALBUMIN; CREATININE; TESTOSTERONE;

ADULT; AGED; ALBUMINURIA; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; CREATININE URINE LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GERMANY; GLOMERULUS FILTRATION RATE; HIGH RISK POPULATION; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SURVIVAL TIME; TESTOSTERONE BLOOD LEVEL;

COHORT STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; TESTOSTERONE;

EID: 79951566257     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000324562     Document Type: Article

References (41)

1. Weiner DE: Public health consequences of chronic kidney disease. Clin Pharmacol Ther 2009; 86: 566-569.
2. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX: Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006; 17:2034-2047. (Pubitemid 44036188)
3. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collabora-tive meta-analysis. Lancet 2010; 375: 2073-2081.
4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New Engl J Med 2004; 351: 1296-1305.
5. Handelsman DJ: Hypothalamic-pituitary gonadal dysfunction in renal failure, dialysis and renal transplantation. Endocr Rev 1985; 6:151-182.
6. Albaaj F, Sivalingham M, Haynes P, McKin-non G Foley RN, Waldek S, O'Donoghue DJ, Kalra PA: Prevalence of hypogonadism in male patients with renal failure. Postgrad Med J 2006; 82: 693-696. (Pubitemid 44786879)
7. Handelsman DJ, Dong Q: Hypothalamo-pi-tuitary gonadal axis in chronic renal failure. Endocrinol Metab Clin North Am 1993; 22: 145-161. (Pubitemid 23079405)
8. Haring R, Volzke H, Steveling A, Krebs A, Felix SB, Schofl C, Dorr M, Nauck M, Wal-laschofski H: Low serum testosterone levels are associated with increased risk of mortal-ity in a population-based cohort of men aged 20-79. Eur Heart J 2010; 31:1494-1501.
9. Carrero JJ, Qureshi AR, Nakashima A, Arv-er S, Parini P, Lindholm B, Barany P, Heim-burger O, Stenvinkel P: Prevalence and clin-ical implications of testosterone deficiency in men with end-stage renal disease. Nephrol Dial Transplant 2011; 26: 184-190.
10. Carrero JJ, Qureshi AR, Parini P, Arver S, Lindholm B, Barany P, Heimburger O, Sten-vinkel P: Low serum testosterone increases mortality risk among male dialysis patients. J Am Soc Nephrol 2009; 20:613-620.
11. Dörr M, Wallaschofski H, Friedrich N: As-sociation of low total testosterone levels and prevalent carotid plaques: result of the Study of Health in Pomerania. Eur J Epidemiol 2009; 24: 389-391.
12. Haring R, Volzke H, Felix SB, Schipf S, Dorr M, Rosskopf D, Nauck M, Schofl C, Wallas-chofski H: Prediction of metabolic syndrome by low serum testosterone levels in men: re-sults from the Study of Health in Pomerania. Diabetes 2009; 58: 2027-2031.
13. Maggio M, Basaria S: Welcoming low testos-terone as a cardiovascular risk factor. Int J Impot Res 2009; 21: 261-264.
14. Volzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, Aumann N, Lau K, Piontek M, Born G, Havemann C, Ittermann T, Schipf S, Haring R, Baumeister SE, Wal-laschofski H, Nauck M, Frick S, Arnold A, Junger M, Mayerle J, Kraft M, Lerch MM, Dorr M, Reffelmann T, Empen K, Felix SB, Obst A, Koch B, Glaser S, Ewert R, Fietze I, Penzel T, Doren M, Rathmann W, Haerting J, Hannemann M, Ropcke J, Schminke U, Jurgens C, Tost F, Rettig R, Kors JA, Ungerer S, Hegenscheid K, Kuhn JP, Kuhn J, Hosten N, Puls R, Henke J, Gloger O, Teumer A, Ho-muth G, Volker U, Schwahn C, Holtfreter B, Polzer I, Kohlmann T, Grabe HJ, Rosskopf D, Kroemer HK, Kocher T, Biffar R, John U, Hoffmann W: Cohort Profile: The Study of Health in Pomerania. Int J Epidemiol, Epub ahead of print.
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rog-ers N, Roth D: A more accurate method to estimate glomerular filtration rate from se-rum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
16. de Jong PE, Curhan GC: Screening, monitor-ing, and treatment of albuminuria: public health perspectives. J Am Soc Nephrol 2006; 17:2120-2126. (Pubitemid 44141901)
17. K/DOQI clinical practice guidelines for chronic kidney disease evaluation, classifi-cation and stratification. Am J Kidney Dis 2002; 39:S1-S266.
18. Friedrich N, Volzke H, Rosskopf D, Steveling A, Krebs A, Nauck M, Wallaschofski H: Ref-erence ranges for serum dehydroepiandros-terone sulfate and testosterone in adult men. J Androl 2008; 29:610-617.
19. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wil-helmsen L, Graham IM: Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24:987-1003. (Pubitemid 36712275)
20. Afifi AA, Kotlerman JB, Ettner SL, Cowan M: Methods for improving regression analy-sis for skewed continuous or counted re-sponses. Annu Rev Public Health 2007; 28: 95-111. (Pubitemid 46833335)
21. Solling K, Christensen CK, Solling J, Chris-tiansen JS, Mogensen CE: Effect on renal haemodynamics, glomerular filtration rate and albumin excretion of high oral protein load. Scand J Clin Lab Invest 1986; 46: 351-357. (Pubitemid 16052928)
22. Corona G, Boddi V, Balercia G, Rastrelli G, De Vita G, Sforza A, Forti G, Mannucci E, Maggi M: The effect of statin therapy on tes-tosterone levels in subjects consulting for erectile dysfunction. J Sex Med 2010; 7:1547-1556.
23. Pencina MJ, DAgostino RB Sr, DAgostino RB Jr, Vasan RS: Evaluating the added pre-dictive ability of a new marker: from area un-der the ROC curve to reclassification and be-yond. Stat Med 2008; 27:157-172. (Pubitemid 351193639)
24. Hallan S, Astor B, Romundstad S, Aasarod K, Kvenild K, Coresh J: Association of kidney function and albuminuria with cardiovascu-lar mortality in older vs younger individuals: The HUNT II Study. Arch Intern Med 2007; 167: 2490-2496. (Pubitemid 350254909)
25. Bhasin S, Cunningham GR, Hayes FJ, Mat-sumoto AM, Snyder PJ, Swerdloff RS, Mon-tori VM: Testosterone therapy in men with androgen deficiency syndromes: an Endo-crine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 95:2536-2559.
26. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR: Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001; 86: 724-731. (Pubitemid 32207487)
27. McLachlan RI: Certainly more guidelines than rules. J Clin Endocrinol Metab 2010; 95: 2610-2613.
28. Haring R, Ittermann T, Volzke H, Krebs A, Zygmunt M, Felix SB, Grabe HJ, Nauck M, Wallaschofski H: Prevalence, incidence and risk factors of testosterone deficiency in a population-based cohort of men: results from the Study of Health in Pomerania. Ag-ing Male 2010; 13: 247-257.
29. Haring R, Baumeister SE, Völzke H, Dorr M, Felix SB, Kroemer HK, Nauck M, Wallas-chofski H: Prospective association of low to-tal testosterone concentrations with an ad-verse lipid profile and increased incident dyslipidemia. Eur J Cardiovasc Prev Rehabil 2010, Epub ahead of print.
30. Haring R, Baumeister SE, Volzke H, Kohl-mann T, Marschall P, Flessa S, Nauck M, Wallaschofski H: Prospective association of low serum total testosterone levels with health care utilization and costs in a popula-tion-based cohort of men. Int J Androl 2010; 33: 800-809.
31. Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N Luben R, Welch A, Day N: En-dogenous testosterone and mortality due to all causes, cardiovascular disease, and can-cer in men: European prospective investiga-tion into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 2007; 116: 2694-2701. (Pubitemid 350291241)
32. Laughlin GA, Barrett-Connor E, Bergstrom J: Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 2008; 93: 68-75.
33. Tivesten A, Vandenput L, Labrie F, Karlsson MK, Ljunggren O, Mellstrom D, Ohlsson C: Low serum testosterone and estradiol pre-dict mortality in elderly men. J Clin Endocri-nol Metab 2009; 94: 2482-2488.
34. Yi S, Selvin E, Rohrmann S, Basaria S, Men-ke A, Rifai N, Guallar E, Platz EA, Astor B: Endogenous sex steroid hormones and mea-sures of chronic kidney disease (CKD) in a nationally representative sample of men. Clin Endocrinol (Oxf) 2009; 71: 246-252.
35. Fortepiani LA, Yanes L, Zhang H, Racusen LC, Reckelhoff JF: Role of androgens in me-diating renal injury in aging SHR. Hyperten-sion 2003; 42: 952-955. (Pubitemid 37413736)
36. Reckelhoff JF, Yanes LL, Iliescu R, Fortepia-ni LA, Granger JP: Testosterone supplemen-tation in aging men and women: possible im-pact on cardiovascular-renal disease. Am J Physiol Renal Physiol 2005; 289:F941-F948. (Pubitemid 41447048)
37. Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR Jette AM, Eder R, Tennst-edt S, Ulloor J, Zhang A, Choong K, Laksh-man KM, Mazer NA, Miciek R Krasnoff J, Elmi A, Knapp PE, Brooks B, Appleman E, Aggarwal S, Bhasin G, Hede-Brierley L, Bha-tia A, Collins L, LeBrasseur N, Fiore LD, Bhasin S: Adverse events associated with tes-tosterone administration. New Engl J Med 2010; 363:109-122.
38. Fernandez-Balsells MM, Murad MH, Lane M, Lampropulos JF, Albuquerque F, Mullan RJ, Agrwal N, Elamin MB, Gallegos-Orozco JF, Wang AT, Erwin PJ, Bhasin S, Montori VM: Clinical review 1: adverse effects of tes-tosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab 2010; 95:2560-2575.
39. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G: Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Im-proving Global Outcomes (KDIGO). Kidney Int 2005; 67:2089-2100. (Pubitemid 41623371)
40. Weiner DE, Krassilnikova M, Tighiouart H, Salem DN, Levey AS, Sarnak MJ: CKD clas-sification based on estimated GFR over three years and subsequent cardiac and mortality outcomes: a cohort study. BMC Nephrol 2009; 10: 26.
41. Liu PY, Death AK, Handelsman DJ: Andro-gens and cardiovascular disease. Endocr Rev 2003; 24:313-340.